-
Searching Blood for Cancer CluesResearchers are developing blood tests that help track and identify molecular changes in tumors. But many hurdles remain before these “liquid biopsies” become standard.
by Stephen Ornes
-
Liver Cancer on the RiseLiver cancer incidence and death rates are increasing rapidly. Although there is no screening test for the disease, minimizing risk factors—hepatitis B and C, smoking, obesity and type 2 diabetes—could prevent many cases from developing.
by Sue Rochman
-
Gaps in End-of-Life CareRacial and ethnic backgrounds can be factors in whether cancer patients take advantage of hospice care. Researchers and clinicians are trying to understand the gaps and design strategies to bridge them.
by Charlotte Huff
-
From the Editor-in-Chief
DNA Profiling Moves From Forensics to DiagnosticsDNA profiling technologies are providing new ways to detect and monitor cancer.
by William G. Nelson, MD, PhD
-
Online Discussions Reveal Little-Known Side EffectsAnalyzing online patient conversations could shed light on adverse drug reactions.
by Brad Jones
-
Is 3-D Mammography Better?A study enrolling patients compares a newer form of digital mammography to conventional 2-D digital mammography.
by Marci A. Landsmann
-
When Cancer Survivors Get Another CancerPatients diagnosed with a second cancer may be unnecessarily excluded from clinical trials.
by Kate Yandell
-
Forward Look
An Overlooked Long-Term Side EffectQ&A with Patricia Ganz on chemotherapy-related nerve damage.
by Sue Rochman
-
Forward Look
Be Alert to Heart HealthRisk of stroke and heart disease increases after a cancer diagnosis.
by Robin Meadows
-
Forward Look
FDA Approves First Biosimilar Cancer TherapyNew product expected to be less expensive.
by Christina Bennett
After caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.
by Miriam Díaz-Gilbert
Screening Options for People With Dense BreastsReports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
